WHPA counterfeit medical products campaign

The World Health Professions Alliance WHPA is extremely concerned about the infiltration and sale of counterfeit medical products of the legitimate supply chain in causing life threatening, adverse effects in patients. (More)

Latest News

21 January 2012: WHPA urges international treaty and civil society expertise to fight falsified and counterfeit medical products
At the 130th Executive Board of the World Health Organization in Geneva, the International Pharmaceutical Federation FIP, on behalf of WHPÄ, presented an intervention which called for.an international treaty against counterfeits as today it is not a crime under international law to trade falsified medicines. The intervention also called for an objective to ensure adequate funding to implement the treaty to be included in the terms of reference for a new Member State mechanism to combat this dangerous public health and patient safety issue. In addition, Member States, via the new mecnahism, were urged to be open to the voice of civil society as emerging channels for SSFFC medicines, like the Internet, require additional expertise.
(See full text here)

Related WHO documentation:
EB130.R13 Resolution: Substandard/spurious/falsely-labelled/falsified/counterfeit medical products
EB130/22 Add.1 Report on financial and administrative implications for the Secretariat of resolutions proposed for adoption by the Executive Board or Health Assembly

Other News

Campaign materials

WHPA Conterfeit Campaign Newsletter

Calendar of Events

Advocacy

WHPA Joint Statement on counterfeit medical products

Contact information

For more information about the WHPA counterfeit medical products campaign, please email